RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM)
Article
Wen, Patrick, Odia, Yazmin, Mehta, Minesh et al. (2020). RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM)
. NEURO-ONCOLOGY, 22(Supplement_2), ii195-ii195. 10.1093/neuonc/noaa215.813
Wen, Patrick, Odia, Yazmin, Mehta, Minesh et al. (2020). RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM)
. NEURO-ONCOLOGY, 22(Supplement_2), ii195-ii195. 10.1093/neuonc/noaa215.813